Pharmaceutical PV DIV - FSB
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DB24D9224
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 59 $198,097 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $198,097 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award, valued at up to $499,999,999, is a single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is with the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of DoD healthcare facilities worldwide. The delivered items include branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, covering a vast array of common and specialized medications such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, oncology drugs, and specialty pharmaceuticals. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for the DLA's pharmaceutical prime vendor programs supporting military medical facilities globally. The sample task orders provided demonstrate the delivery of specific pharmaceutical products, including Xtandi, Kyleena, Mirena, and Surgilube, to the DLA under this IDC.
Task orders
Show 40 more
Latest 50 of 59 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB24D9224?
SPE2DB24D9224 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 11, 2024.
How much is contract SPE2DB24D9224 worth?
Orders under SPE2DB24D9224 have obligated $198,097. SPE2DB24D9224's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB24D9224?
59 orders have been placed under SPE2DB24D9224, the latest on September 24, 2025.
Who can order from contract SPE2DB24D9224?
SPE2DB24D9224 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB24D9224 competed?
The extent of competition for SPE2DB24D9224 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV